Newscrate logo

Browse the latest blood cancer news online for free

Search results for "blood cancer"

New therapy offers lifeline to ‘incurable’ blood cancer patients
New therapy offers lifeline to ‘incurable’ blood cancer patients

Almost two thirds of participants in the immunotherapy trial are disease-free three years on Read more

The Times - Dec 09
FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep
FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep

On Friday, the U.S. Food and Drug Administration (FDA) approved GSK Plc’s (NYSE:GSK) Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for adult patients with relapsed or refractory multiple myeloma who have received at least two prior lines of therapy.The... Read more

Benzinga - Oct 24
‘I thought I had injured my back - but it was incurable blood cancer’
‘I thought I had injured my back - but it was incurable blood cancer’

More than 33,000 people in the UK are living with myeloma - a type of incurable blood cancer that causes bone pain Read more

The Independent - Sep 13
Incurable blood cancer patients now living twice as long, study finds
Incurable blood cancer patients now living twice as long, study finds

Multiple myeloma is incurable, and happens when the bone marrow makes abnormal white blood cells Read more

The Independent - Sep 03
Chris Foreman, Madness guitarist, reveals he has incurable blood cancer diagnosis
Chris Foreman, Madness guitarist, reveals he has incurable blood cancer diagnosis

"I have a long way to go before I get back onstage but I aim to be back next year"The post Chris Foreman, Madness guitarist, reveals he has incurable blood cancer diagnosis appeared first on NME. Read more

Nme - Aug 30
Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79%
Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79%

Genmab A/S (NASDAQ:GMAB) released results Thursday of the Phase 3 EPCORE FL-1 trial evaluating subcutaneous epcoritamab in combination with rituximab and lenalidomide (R2) versus R2 alone for adult patients with relapsed or refractory (R/R) follicular lymphoma (FL).The study met its dual primary ... Read more

Benzinga - Aug 08